Clinical Trial Update: Clinical Use of Pathogen Reduced Red Blood Cell Suspension [Phase 3]

View source ↗

Summary

Phase 3 trial update on the clinical use of pathogen-reduced red blood cell suspension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Oncologic Disorders

Drugs mentioned

• Pathogen Reduced Red Blood Cell Suspension

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Oncologic Disorders, Hematologic Diseases | Phase 3 | Status: COMPLETED